Sterling Group Holdings Limited (HKG:1825)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	38	26	30	32	47	178
Market Cap Growth	-14.75%	-14.75%	-6.72%	-31.57%	-73.66%	102.73%
Enterprise Value	133	125	147	129	251	403
Last Close Price	0.11	0.07	0.13	0.13	0.23	0.89
PE Ratio	-	-	-	1.61	-	-
PS Ratio	0.08	0.05	0.05	0.05	0.10	0.48
PB Ratio	1.25	0.84	1.10	0.68	1.75	3.13
P/TBV Ratio	4.35	2.92	5.56	1.30	14.36	5.70
P/FCF Ratio	0.60	-	-	0.88	2.76	-
P/OCF Ratio	0.60	-	-	0.85	2.41	-
EV/Sales Ratio	0.28	0.26	0.26	0.21	0.55	1.09
EV/EBITDA Ratio	7.01	7.46	296.39	3.61	-	-
EV/EBIT Ratio	11.18	10.51	-	4.20	-	-
EV/FCF Ratio	2.10	-	-	3.54	14.77	-
Debt / Equity Ratio	3.58	3.58	7.10	3.21	7.20	4.33
Debt / EBITDA Ratio	6.54	6.54	92.21	3.78	-	-
Debt / FCF Ratio	-	-	-	4.14	11.36	-
Asset Turnover	1.67	1.67	1.83	1.99	1.29	0.98
Inventory Turnover	16.00	16.00	11.82	11.12	10.41	9.29
Quick Ratio	0.34	0.34	0.63	0.57	0.59	0.66
Current Ratio	0.46	0.46	0.78	0.80	0.76	0.79
Return on Equity (ROE)	-21.24%	-21.24%	-49.40%	53.97%	-92.66%	-58.49%
Return on Assets (ROA)	2.59%	2.59%	-0.87%	6.15%	-8.27%	-5.75%
Return on Capital (ROIC)	4.10%	4.10%	-1.30%	9.20%	-11.19%	-7.18%
Return on Capital Employed (ROCE)	28.30%	28.30%	-	51.60%	-	-
Earnings Yield	-16.16%	-24.02%	-61.20%	61.96%	-82.65%	-18.64%
FCF Yield	166.13%	-	-62.20%	113.40%	36.20%	-5.80%
Buyback Yield / Dilution	-17.83%	-17.83%	-12.50%	-6.67%	-	-

Updated Dec 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.